Incyte Corp (NASDAQ: INCY) has a higher price-to-earnings ratio of 484.69x compared to its average ratio, The 36-month beta value for INCY is at 0.70. Analysts have varying views on the stock, with 12 analysts rating it as a “buy,” 5 rating it as “overweight,” 13 as “hold,” and 0 as “sell.”
The public float for INCY is 189.60M, and currently, shorts hold a 3.91% of that float. The average trading volume for INCY on November 19, 2024 was 1.91M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
INCY) stock’s latest price update
Incyte Corp (NASDAQ: INCY)’s stock price has decreased by -11.08 compared to its previous closing price of 76.97. However, the company has seen a -15.07% decrease in its stock price over the last five trading sessions. investors.com reported 2024-11-19 that Incyte stock tumbled Tuesday after the company scrapped one drug and paused enrollment in the study of another. The post Incyte Collapses.
INCY’s Market Performance
INCY’s stock has fallen by -15.07% in the past week, with a monthly rise of 4.85% and a quarterly rise of 6.69%. The volatility ratio for the week is 3.21% while the volatility levels for the last 30 days are 3.07% for Incyte Corp The simple moving average for the last 20 days is -8.76% for INCY stock, with a simple moving average of 10.53% for the last 200 days.
Analysts’ Opinion of INCY
Many brokerage firms have already submitted their reports for INCY stocks, with BofA Securities repeating the rating for INCY by listing it as a “Buy.” The predicted price for INCY in the upcoming period, according to BofA Securities is $90 based on the research report published on October 29, 2024 of the current year 2024.
Wolfe Research, on the other hand, stated in their research note that they expect to see INCY reach a price target of $84. The rating they have provided for INCY stocks is “Outperform” according to the report published on October 01st, 2024.
Truist gave a rating of “Hold” to INCY, setting the target price at $74 in the report published on September 18th of the current year.
INCY Trading at -1.37% from the 50-Day Moving Average
After a stumble in the market that brought INCY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -18.48% of loss for the given period.
Volatility was left at 3.07%, however, over the last 30 days, the volatility rate increased by 3.21%, as shares surge +3.54% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.57% upper at present.
During the last 5 trading sessions, INCY fell by -15.72%, which changed the moving average for the period of 200-days by +16.97% in comparison to the 20-day moving average, which settled at $74.99. In addition, Incyte Corp saw 9.00% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at INCY starting from Flannelly Barry P, who sale 3,680 shares at the price of $79.68 back on Nov 06 ’24. After this action, Flannelly Barry P now owns 58,042 shares of Incyte Corp, valued at $293,210 using the latest closing price.
BARRY FLANNELLY, the Officer of Incyte Corp, proposed sale 3,680 shares at $79.68 during a trade that took place back on Nov 06 ’24, which means that BARRY FLANNELLY is holding shares at $293,210 based on the most recent closing price.
Stock Fundamentals for INCY
Current profitability levels for the company are sitting at:
- -0.01 for the present operating margin
- 0.92 for the gross margin
The net margin for Incyte Corp stands at 0.01. The total capital return value is set at -0.01. Equity return is now at value 0.80, with 0.57 for asset returns.
Currently, EBITDA for the company is 919.43 million with net debt to EBITDA at -5.75. When we switch over and look at the enterprise to sales, we see a ratio of 2.91. The receivables turnover for the company is 5.37for trailing twelve months and the total asset turnover is 0.81. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.87.
Conclusion
In conclusion, Incyte Corp (INCY) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
